Evaluation of a card collection-based faecal immunochemical test in screening for colorectal cancer using a two-tier reflex approach

Gut

Volumn 56, Issue 10, 2007, Pages 1415-1418

  Fraser, Callum G ^a   Mathew, Catriona M ^a   Mowat, N Ashley G ^b   Wilson, John A ^c   Carey, Francis A ^d   Steele, Robert J C ^d  

^a Scottish Bowel Screening Centre Laboratory   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^c VICTORIA HOSPITAL   (United Kingdom)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMA; ADULT; AGED; ARTICLE; COLONOSCOPY; COLORECTAL CANCER; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; FEMALE; GUAIAC FECAL OCCULT BLOOD TEST; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECTUM POLYP; SCREENING; SENSITIVITY AND SPECIFICITY;

ADENOMATOUS POLYPS; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PATIENT PARTICIPATION; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING;

EID: 34948883197     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2007.119651     Document Type: Article

References (17)

1. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
2. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer using faecal occult blood test. Lancet 1996;348:1467-71.
3. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-71.
4. Steele RJC, Parker R, Patnick J, et al. A demonstration pilot trial for colorectal cancer screening in the United Kingdom: a new concept in the introduction of healthcare strategies. J Med Screen 2001;8:197-202.
5. Young GP, St John DJ, Winawer SJ, et al for WHO and OMED (World Organization for Digestive Endoscopy). Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO and OMED report. Am J Gastroenterol 2002;97:2499-507.
6. Selinger RR, Norman S, Domnitz JA. Failure of health care professionals to interpret fecal occult blood tests accurately. Am J Med 2003;114:64-7.
7. Allison JE. Colon cancer screening guidelines 2005: the fecal occult blood test option has become a better FIT. Gastroenterology 2005;129:745-48.
8. Allison JE, Lawson M. Screening tests for colorectal cancer: a menu of options remains relevant. Curr Oncol Rep 2006;8:492-8.
9. Fraser CG, Matthew CM, Mowat NAG, et al. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study. Lancet Oncol 2006;7:127-31.
10. NHS Quality Improvement Scotland. Clinical standards: Bowel Screening Programme 2007.
11. Atkin WS, Saunders BP. Surveillance guidelines after removal of colorectal adenomatous polyps. Gut 2002;51(Suppl v):v6-vv9.
12. Cole SR, Young GP, Esterman A, et al. A randomized trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer J Med Screen 2003;10:117-22.
13. UK Colorectal Cancer Screening Pilot Group. Results of the first round of a demonstration pilot of colorectal cancer screening in the United Kingdom. BMJ 2004;329:133-5.
14. Ransohoff DF. Lessons from the UK sigmoidoscopy screening trial [editorial]. Lancet 2002;359:1266-7.
15. Eide T, Risk of colorectal cancer in adenoma bearing individuals within a defined population. Int J Cancer 1986;38:173-6.
16. Scottish Executive Department of Health. Bowel Screening Programme. HDL (2006)3. http://www.sehd.scot.nhs.uk/mels/HDL2006_03.pdf (accessed 21 Mar 2007).
17. Anon. Immunochemical versus guaiac fecal occult blood tests. Technol Eval Cent Assess Program 2004;19:1-28.